MD, MPH, PhD
Nancy A. Dreyer Distinguished Professor
UNC Gillings School of Global Public Health
Area of Interest
I am the Nancy A. Dreyer Distinguished Professor and Chair of the Department of Epidemiology, UNC-Chapel Hill Gillings School of Global Public Health. My career as a medical researcher started with assessing the role of analgesics on kidney function and mortality, which culminated in a paper in the New England Journal of Medicine. After my formal training in epidemiology at Harvard School of Public Health, I continued pharmacoepidemiologic research with analyses of the role of nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin on cognitive function, risk for colorectal cancer (CRC), and kidney function.
Since 2003, I have focused on pharmacoepidemiology, developing and implementing methods to improve validity of non-experimental research on the effects of medical interventions on clinically relevant outcomes based on real world data. As former Director of the Center for Pharmacoepidemiology and past President of the International Society for Pharmacoepidemiology, I am very glad to have been able to assemble an outstanding interdisciplinary team of researchers with expertise in epidemiology, pharmacoepidemiology, internal medicine, and biostatistics from within and outside of UNC to advance our methodological armamentarium to provide valid evidence for effectiveness and safety of pharmacotherapies.
News and Stories
Lund, Henderson awarded NCI grant to study impacts of low-dose CT lung cancer screening outside clinical trials
Jennifer Lund, PhD, MSPH, and Louise Henderson, PhD, will use the $1.76 million grant to study the real-world benefits and harms of lung cancer screening with low-dose computed tomography.